Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries with almost 25% affected adults worldwide. The growing public health burden is getting evident when considering that NAFLD-related liver transplantations are predicted to almost double within the n...

Full description

Bibliographic Details
Main Authors: Hannah K. Drescher, Sabine Weiskirchen, Ralf Weiskirchen
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cells
Subjects:
nonalcoholic steatohepatitis
fibrosis
grading
staging
imaging
algorithms
scores
biomarkers
Online Access:https://www.mdpi.com/2073-4409/8/8/845

Similar Items

Similar Items